Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts (Q41009444)

25 September 2017

Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation endproducts (English)

1 reference

25 September 2017

1 reference

Park L

1

1 reference

25 September 2017

Raman KG

2

1 reference

25 September 2017

Lee KJ

3

1 reference

25 September 2017

Lu Y

4

1 reference

25 September 2017

Ferran LJ Jr

5

1 reference

25 September 2017

Chow WS

6

1 reference

25 September 2017

Stern D

7

1 reference

25 September 2017

Schmidt AM

8

1 reference

25 September 2017

language of work or name

English

0 references

publication date

1 September 1998

1 reference

25 September 2017

1 reference

25 September 2017

4

1 reference

25 September 2017

1025-1031

1 reference

25 September 2017

9

1 reference

https://scigraph.springernature.com/pub.10.1038/2012

25 September 2017

0 references

cites work

5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects.

1 reference

7 January 2021

Diabetes and cardiovascular disease. The Framingham study

1 reference

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

7 January 2021

Glucose and diabetic vascular disease.

1 reference

7 January 2021

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications

1 reference

7 January 2021

Advanced glycation end products (AGEs) on the surface of diabetic erythrocytes bind to the vessel wall via a specific receptor inducing oxidant stress in the vasculature: a link between surface-associated AGEs and diabetic complications

1 reference

7 January 2021

Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of dia

1 reference

7 January 2021

The receptor for advanced glycation end products (RAGE) is a central mediator of the interaction of AGE-beta2microglobulin with human mononuclear phagocytes via an oxidant-sensitive pathway. Implications for the pathogenesis of dialysis-related amyl

1 reference

7 January 2021

Receptor for advanced glycation end products (AGEs) has a central role in vessel wall interactions and gene activation in response to circulating AGE proteins

1 reference

7 January 2021

Receptor-mediated endothelial cell dysfunction in diabetic vasculopathy. Soluble receptor for advanced glycation end products blocks hyperpermeability in diabetic rats

1 reference

7 January 2021

Increased atherosclerosis in streptozotocin-induced diabetic mice

1 reference

7 January 2021

Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E

1 reference

7 January 2021

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

1 reference

7 January 2021

Streptozotocin-Induced Pancreatic Insulitis: New Model of Diabetes Mellitus

1 reference

7 January 2021

Metabolic control in 131 juvenile-onset diabetic patients as measured by HbA1c: relation to age, duration, C-peptide, insulin dose, and one or two insulin injections.

1 reference

7 January 2021

ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree

1 reference

7 January 2021

Quantitative assessment of atherosclerotic lesions in mice

1 reference

7 January 2021

The dark side of glucose

1 reference

7 January 2021

Immunological evidence for the presence of advanced glycosylation end products in atherosclerotic lesions of euglycemic rabbits

1 reference

7 January 2021

Activation of the receptor for advanced glycation end products triggers a p21(ras)-dependent mitogen-activated protein kinase pathway regulated by oxidant stress.

1 reference

7 January 2021

The role of oxidized lipoproteins in atherogenesis

1 reference

7 January 2021

Is hyperglycemia associated with cardiovascular disease? The Framingham Study

1 reference

7 January 2021

A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection

1 reference

7 January 2021

Molecular identity and cellular distribution of advanced glycation endproduct receptors: relationship of p60 to OST-48 and p90 to 80K-H membrane proteins.

1 reference

7 January 2021

THE DISTRIBUTION AND CHEMICAL COMPOSITION OF ULTRACENTRIFUGALLY SEPARATED LIPOPROTEINS IN HUMAN SERUM

1 reference

7 January 2021

The role of lipid peroxidation and antioxidants in oxidative modification of LDL.

1 reference

7 January 2021

Effect of the antioxidant N,N'-diphenyl 1,4-phenylenediamine (DPPD) on atherosclerosis in apoE-deficient mice

1 reference

7 January 2021

Identifiers

DOI

10.1038/2012

1 reference

25 September 2017

1 reference